4880

CellSource Co.,Ltd.

セルソース

Industry
Pharmaceutical
Market
Standard
Accounting standards
Japanese GAAP
Consolidation basis
Consolidated

Notes

  • Consolidation basis
    Consolidated / Since Oct 2025
  • Stock adjustments
    Nov 1, 2020 Stock split 1 share → 3 shares
  • Stock adjustments
    Nov 1, 2021 Stock split 1 share → 3 shares

Key metrics

Revenue(thousand JPY)

Oct 2021
2,922,232
Oct 2022
4,273,829
Oct 2023
4,510,544
Oct 2024
4,355,063
Oct 2025
3,711,455

Operating profit(thousand JPY)

Oct 2021
992,441
Oct 2022
1,571,052
Oct 2023
1,221,499
Oct 2024
129,158
Oct 2025
166,708

Operating profit margin(%)

Oct 2021
33.96
Oct 2022
36.76
Oct 2023
27.08
Oct 2024
2.97
Oct 2025
4.49

Profit before tax(thousand JPY)

Oct 2021
1,006,367
Oct 2022
1,583,639
Oct 2023
1,239,682
Oct 2024
294,941
Oct 2025
109,846

Profit(thousand JPY)

Oct 2021
651,396
Oct 2022
1,017,842
Oct 2023
923,142
Oct 2024
237,940
Oct 2025
10,659

Total assets(thousand JPY)

Oct 2021
3,365,353
Oct 2022
4,599,680
Oct 2023
6,879,736
Oct 2024
7,074,909
Oct 2025
7,023,969

Cash and cash equivalents(thousand JPY)

Oct 2021
2,409,322
Oct 2022
3,123,580
Oct 2023
4,781,022
Oct 2024
4,320,915
Oct 2025
4,711,820

Cash flows from operating activities(thousand JPY)

Oct 2021
898,194
Oct 2022
847,603
Oct 2023
846,691
Oct 2024
591,723
Oct 2025
333,095

Cash flows from investing activities(thousand JPY)

Oct 2021
-256,117
Oct 2022
-169,388
Oct 2023
-624,080
Oct 2024
-614,961
Oct 2025
-3,292

Cash flows from financing activities(thousand JPY)

Oct 2021
9,347
Oct 2022
14,421
Oct 2023
1,449,123
Oct 2024
-437,244
Oct 2025
61,071

Return on equity(%)

Oct 2021
27.5
Oct 2022
31.6
Oct 2023
18.7
Oct 2024
3.9
Oct 2025
0.2

Equity ratio(%)

Oct 2021
80.3
Oct 2022
81.4
Oct 2023
89.4
Oct 2024
84.7
Oct 2025
84

Earnings per share(JPY per share)

Oct 2021
11.7233
Oct 2022
54.54
Oct 2023
48.88
Oct 2024
12.02
Oct 2025
0.54

Net assets per share(JPY per share)

Oct 2021
48.38
Oct 2022
200.37
Oct 2023
311.25
Oct 2024
302.52
Oct 2025
297.8

Dividend per share(JPY per share)

Oct 2021
-
Oct 2022
-
Oct 2023
20
Oct 2024
5
Oct 2025
5

Payout ratio(%)

Oct 2021
-
Oct 2022
-
Oct 2023
40.92
Oct 2024
41.6
Oct 2025
925.93

Disclaimer

The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.

The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.